Riskpilot← Back to searchSign inGet full accessDr. Rekond AB
ABActiveOrg 5592470966Bjuvsleden 8Repair and maintenance of motor vehicles · NACE 9531Est. 20201-4 employees
Revenue 2025
SEK 2,2M
+23% vs 2024
EBITDA margin
-12.9%
-261% vs 2024
Equity ratio
-13.6%
Financial strength
Net profit 2025
SEK -306K
-451% vs 2024
| Revenue | SEK 2,2M | +23% |
| EBITDA | SEK -281K | -261% |
| Net profit | SEK -306K | -451% |
| Total assets | SEK 1,3M | +365% |
| Equity | SEK -179K | -242% |
| Employees | — | — |
Legal name
Dr. Rekond AB
Org number
5592470966
Legal form
Aktiebolag
NACE code
9531 · Repair and maintenance of motor vehicles
Founded
10 mars 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets ska bedriva handel, reparationer, service och bilvård av personbilar och lätta motorfordon.
Address
Bjuvsleden 8
Email
slavkonikolic1987@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 132 | 2 543 | 1 408 | 1 775 | 2 178 |
| Staff expenses | — | −682 | −198 | −16 | −238 |
| EBITDA | 36 | −49 | 181 | 174 | −281 |
| Depreciation & amort. | −15 | −21 | −23 | −5 | −15 |
| EBIT | 21 | −70 | 158 | 169 | −296 |
| Net financials | −29 | −14 | −46 | −59 | −10 |
| Profit before tax | −8 | −84 | 113 | 110 | −306 |
| Tax | −0 | — | −6 | −23 | — |
| Net profit | −8 | −84 | 106 | 87 | −306 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 300 | 270 | 204 | 282 | 1 313 |
| Equity | 17 | −67 | 40 | 127 | −179 |
| Long-term debt | 107 | 224 | 37 | 0 | 1 287 |
| Short-term debt | 175 | 112 | 128 | 156 | 206 |
| Total debt | 282 | 337 | 164 | 156 | 1 493 |
EBITDA margin
-12.9%
This company
15.8%
Market median
-182% vs market
20212025
Equity ratio
-13.6%
This company
38.2%
Market median
-136% vs market
20212025
Return on equity
-30590000.0%
This company
18.4%
Market median
-166250100% vs market
20212025
Net profit margin
-14.0%
This company
8.1%
Market median
-273% vs market
20212025
Asset turnover
1.66×
This company
1.12×
Market median
+48% vs market
20212025
Debt / equity
8.33×
This company
0.62×
Market median
-1244% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-05-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Rekond AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Natalia Georgeta Soflete | Deputy Board Member | 0 companies |
| Aida Andersson | Deputy Board Member | 0 companies |
| Slavko Nikolic | Board of Directors | 0 companies |